by BGIS | Jan 7, 2019 | Top Stories
Statement from the Ministry of Health and Wellness on Valsartan 160mg and 320mg, and Indapamide 1.5mg Recall The Ministry of Health and Wellness wishes to inform Barbadians that recent analytical results from the Medicines Quality Control and Surveillance Department...
by Joy Springer | Jan 5, 2019 | Top Stories
The Ministry of Health and Wellness is assuring the public that none of the drugs identified in the December 31 recall of the hypertensive drug, Valsartan, by the United States Food and Drug Administration (FDA) is approved by the Barbados Drug Service for sale in...
by Joy Springer | Dec 17, 2018 | Top Stories
The Ministry of Health and Wellness has assured the public that Barbados has not been affected by the current recall of the hypertensive drug, Valsartan. The drug has been recalled due to an impurity found in a batch of products. Acting Chief Medical Officer, Dr....
by BGIS | Jul 17, 2018 | Top Stories
It has been brought to the attention of the Ministry of Health and Wellness that some batches of Valsartan, a popular drug used to treat high blood pressure, is the subject of an international recall. The drug, which belongs to the class angiotensin receptor blocker,...
